# BUPRENORPHINE
> **ANDA210162** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN TECH VIATRIS · Approved 2021-05-03
## Drug
- **FDA Application Number:** ANDA210162
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPRENORPHINE
- **Generic name:** Buprenorphine
- **Active ingredients:** BUPRENORPHINE
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN TECH VIATRIS
- **First approval:** 2021-05-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210162)
---
*AI Analytics · CC0 1.0*